Glasgow Scotland
All Events

ISPOR Europe 2025

  • Start Date:

    09 Nov 2025

  • End Date:

    12 Nov 2025

  • Location:

    Glasgow, Scotland

  • Region:

    Europe

  • Booth #:

    804

Get in touch

Powering value and access

Our multi-disciplinary team provides strategic insight, commercial acumen, scientific prowess and technical proficiency to enable you to bring life-changing treatments to patients, faster.

From early pipeline planning to post-market access, our expertise spans the full product life cycle. Whether you need robust health economic models, real-world outcomes research, patient preference and utility studies, or strategic market access guidance, we deliver customized solutions tailored to your unique challenges.

Partner with us to harness the power of real-world evidence and shape the future of health care with confidence.

Get in touch
ispor-corporate-partner-seal-2025

ISPOR Europe 2025 conference website

Explore our ISPOR 2025 sessions and insights
ispor-corporate-partner-seal-2025

ISPOR Europe 2025 conference website

Educational symposium

Monday, 10 November • 11:45am – 12:45pm
Strategic Insights from 5 Years of the EU HTA Regulation: Unleashing the Ambition for Orphan Products and Vaccines

Speakers: Martin Parkinson, Caroline Delaitre, Samantha James, Ruth Chapman

Issue panel

Tuesday, 11 November • 13:45pm – 14:45pm
Trusting a Machine? Opportunities and Challenges to Using Artificial Intelligence in Qualitative Patient Research

Speaker: Karen Bailey

Wednesday, 12 November • 8:00am – 9:00am
The Variable Thresholds Issue: A Necessary Tool or a Misguided Obsession?

Speaker: J. Jaime Caro

Wednesday, 12 November • 10:00am – 11:00am
Handling Transitions between Child and Adult HRQoL in Economic Evaluation

Speaker: Louis Matza

Forum

Tuesday, 11 November • 13:15pm – 14:15pm
Harmonizing and Enabling Cross-Border Real-World Evidence Studies in Europe

Moderator: Ashwin Rai

Workshops

Monday, 10 November • 13:45pm – 14:45pm
COAs and Patient Preference Information: Building on a Promising but Challenging Relationship

Moderator: Sebastian Heidenreich

Monday, 10 November • 5:00pm – 6:00pm
Real-World Evidence – From the Clinician’s Perspective

Moderator: Susan Oliveria
Speaker: John Sampalis

Tuesday, 11 November • 10:15am – 11:15am
Building Multi-Agent AI Systems to Reduce Subject Matter Expert Burden in Health Economics Research

Moderator: J. Jaime Caro

Tuesday, 11 November • 5:00pm – 6:00pm
A Match Made in Heaven? Optimal Selection of Preference Elicitation Methods to Address Study Purpose and Objectives

Moderator: Jennifer Whitty

Research podiums

Tuesday, 11 November • 10:15am – 11:15am
Preferences in Frail and Older Patient Populations

Session title: Assessment of Mortality and COPD Exacerbations in GOLD E COPD Patients in the Netherlands

Authors: Kathryn Evans, Noami Berfeld

Tuesday, 11 November • 5:00pm – 6:00pm
Measuring Health-Related Quality of Life Across the Lifespan

Session title: Eliciting Preferences for Combination Vaccines Protecting Against Multiple Respiratory Viruses: A Cross-Sectional Discrete Choice Experiment of Adults Aged 50 in the US

Authors: Keila Meginnis, Matthew Quaife

Poster presentations

Monday, 10 Nov

Session 1

A Layered Approach to Reducing Hallucinations in LLMs for Structured and Unstructured Clinical Data

Rai AK, Bhandary D, Ikoro V, Ng A

Anchors Away: Navigating Unanchored Indirect Comparisons with Multilevel Unanchored Meta-regression (ML-UMR)

Chandler C, Ishak J

Can simple treatment effect waning mechanics be used to help explore alternative extrapolation scenarios when curve crossing is present?

Kazmierska P, Aminnejad N, Bungey G

Economic Burden Utilities and Cost Effectiveness of Perioperative Immunotherapies for Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)

Priedane E, Farraia M, Pandey A, Ng J , von Wilamowitz-Moellendorff C

Assessment of Health State Utiliites Associated with Treatment for Chronic Hepatitis B Virus (HBV) Infection

Howell T, Matza L, Martin A, Nikitas FS, Begaj K, Theodore D, Agarwal K, Sulkowski M, Coffin C, Dolman G, Kendrick S, Das J, Ismaila A

Cross-Sectional Cohort Designs Offers An Efficient Alternative to Prospective Cohort Design in Real-World Studies (RWS)

Neil Brett, Marielle Bassel, Vincent McCarty, John Sampalis

AI-Assisted Time-to-Event Projection: A Case Study and Broader Potential

Jack Ishak, Jaime Caro

Challenges in predicting the Joint Clinical Assessment (JCA) scope from a stakeholder perspective: a case study in Relapsed/Refractory Multiple Myeloma

Kaisa Miikkulainen, Maria Victoria Mateos Manteca, Caroline Delaitre-Bonnin, Almudena Olid Gonzalez, Milon Waththuhewa, Aleksandra Zapala-Szufel, Benedikte Lensberg, Brett Doble, Damla Kilic.

A Systematic Review of Trends from Migraine Preference Studies

Natasha Ramachandran, Harrison Clarke, Divya Mohan, Jaein Seo

A Review of Information Uncertainty in Oncology Treatment Preferences

Hui Lu

Monday, 10 Nov

Session 2

Development and Implementation of a Dynamic Framework for Assessment and Improvement of Registries’ Data Quality

Duong M, Justo N, Berfeld N, Pettersson C, Nguyen H, Kastrva K, Matyushenko V, Mokrá L, Farjana A, Bennett N, Watson E, Masic D, Poll A

Enhancing Targeted Literature Reviews (TLRs) with Artificial Intelligence (AI): A Methodological Approach for Conducting Efficient Targeted Searches

von Wilamowitz-Moellendorf C, Wittkopf P, Goel R, Ronnebaum S

Evaluating High-Cost Gene Therapies for Non-Cancer Conditions: Insights From NICE’s Standard Appraisal Process

Stapleton N, Dvorkina M, Kumichel A

Estimating Lost Life-Years and Quality-Adjusted Life-Years Of Under-Treatment Of Patients With Renal Cell Carcinoma and Metastatic Pancreatic Cancer In England

Berdunov V, Hughes R, Smith M

Evidence of Mapping Malpractice? A Review of Mapping Algorithm Usage in NICE Health Technology Appraisals

Spencer C, Bungey G, Saramago Goncalves P, Baginska-Dudek B, Nagy E, Szabo G, Winter K, D’Errico M, de Boisvilliers S

Cost Implications of Declining MMR Coverage in England: Modelling NHS Burden and the Value of Catch-Up Vaccination

Winter K, Pinsent A

Cost-Effectiveness of CKD Screening: Insights for the 60+ General Population and Those With Type 2 Diabetes

Bungey G, de Boisvilliers S, Spencer C, Espego J, Tichy E, von Wilamowitz-Moellendorf C, Wittkopf P

Data Reliability in Retrospective Chart Review Studies: Results and Considerations From a Novel Data Review Methodology

Neil Brett, Luke Safarcyk, Elizabeth Donahue, Marielle Bassel

Exploring knowledge, attitudes and perspectives on respiratory virus vaccination among older adults in the US

Matthieu Beuvelet, Caroline de Courville, Maribel Tribaldos, Antonio Robles, Gabriela Fernandez, Hannah Collacott, Matthew Quaife

EQ-5D utility impact of worsening NYHA class and CV hospitalization (CVH) on health-related quality of life (HRQoL) of patients with ATTR-CM based on the ATTRibute-CM trial

Irina Proskorovsky, Mira Krotneva, Ágnes Benedict, Maria Hülsebeck, Heather Falvey

Framing Matters! Implications of Loss Aversion for Communicating Benefits to Patients in Preference Studies (and Beyond)

Hui Lu, Joshua Coulter, Travis Gould, Lisa Wilcox, Carmine Colavecchia, Stephanie Christopher, Álvaro Gutiérrez, Brett Hauber, Jennifer Whitty

Exploring the promise of generative AI for coding and analysing qualitative patient data: Results from a pilot study in Non-Hodgkin’s Lymphoma

Bailey K, Skalicky A, Dias-Barbosa C, Stanczyk S

Tuesday, 11 Nov

Session 3

Identifying Risk Profiles for Early Treatment Discontinuation in Geographic Atrophy Using Machine Learning and SHAP Clustering

Rai AK, Boucher N, Berger A, Ishii F, Ikoro V, Bhandary D, Ng A

Funding the Fight Against Antimicrobial Resistance: Learnings from the UK and Sweden’s Pilot Incentive Programmes

Beugre-Guyot M, Hearne E, Boss J

Have Delays in Vaccine Market Access Improved in Europe and the US Over the Last Decade?

James S, D’Ausilio A, Boss J, Chapman R, Schaible K, Zapala Szufel A

From Theory to Practice: Guidance for Identifying and Selecting Mapping Algorithms for Health Economic Models

Bungey G, von Wilamowitz-Moellendorf C, Bajko P, Duffy S, Proskorovsky I

Systematic Literature Review (SLR) of Efficacy, Health-Related Quality of Life (HRQoL), and Safety of Immunotherapies for Perioperative Treatment of Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Priedane E, Farraia M, Pandey A, Ng J, von Wilamowitz-Moellendorff C

Integrating Real-World Evidence For Advanced Therapies In Inflammatory Bowel Disease Into Re-Imbursement Submissions: Insights And Considerations From The UK

Neil Brett, Garthiga Manickam, Roy Mootoosamy, Daniela Castano, John S. Sampalis

Importance of Adjudication Committees in Retrospective Chart Review Studies for Outcomes Event Data Collection

Marielle Bassel, Paul Daniel Bibat, Kelly Donham

Integrating Real-World Evidence into Oncology HTA Submissions: Recent EU Examples

Ivana Sestak, Janneke Luijken, Fang-Yi Lin, Sara Angleman, Alice Rouleau

From JCA to Local P&R: Evaluating Impact Across Europe

Nebibe Varol, Laetitia Gelbert, Caroline Delaitre-Bonnin, Paulina Rolska-Wójcik

How Chinese restaurants can help with robust preference insights: A novel Dirichlet mixture model to account for complex heterogeneity in individual preference weights

Keila Meginnis, Nicolas Krucien, Christine Michaels-Igbokwe, Caitlin Thomas, Sebastian Heidenreich

Health State Utilities Associated with Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Steward K, Matza L, Guo K, Ridley C, Lorenzo MM, Lee S, Mbagwu M, Patel P, Matthews S, Burton D, Doyle S

Long-term experience and quality of life of patients with ALK positive advanced NSCLC (ALK+ aNSCLC) who receive 1L lorlatinib for more than 4 years

Liu G, Clucas C, Skalicky A, Rifi N, Lusk J, Le H

Tuesday, 11 Nov

Session 4

Millennial Medical Record (MMR) Data Profile: A Japanese Electronic Medical Records (EMR) Database Utilising Unstructured Data for Lung Cancer Research

Hamaguchi A, Shiba K, Kato M, Wakasugi D, Koga T, Nozue S, Sawada T, Morita T, Pulfer A, Lambrelli D

Real-world cancer treatments for common solid tumors in China: a targeted literature review

Li Z, Ban L, Raluy-Callado M

NICE Has Embraced Single-Arm Trials in Technology Appraisals, but Where is the Guidance?

Karinou E, Mitchell C, Rawson K

Public Health Impact of 25 Years of Pneumococcal Conjugate Vaccination of Children 5 Years Old: A Modelling Analysis

Chapman R, Dillon-Murphy D

Navigating HTA Requirements: The Current Landscape of Alzheimer’s Disease Modifying Treatments

So D, Molencap V, Abi-Saleh N

Real-World Evidence on the Broader Benefits of GLP-1RA-Based Therapies: A Global Targeted Literature Review

Gibbs K, Jennings E, Monica M, Mootoosamy R

Methods for Incidence Progression Estimation in Partitioned Survival Analysis: Does the Chosen Method Matter?

Sadeghimehr M, Rivolo S, Bungey G

Navigating Evidence Requirements for Joint Clinical Assessment (JCA): Practical Considerations for Systematic Literature Review (SLR) and Indirect Treatment Comparisons (ITC)

von Wilamowitz-Moellendorf C, Bajko P, Gonzalez E, Deshpande S

Real-World Effectiveness Of Immune Checkpoint Inhibitors + Chemotherapy (ICI+CT) Versus ICI Monotherapy (ICI) In Untreated Locally Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Targeted Literature Review

Farraia M, Priedane E, Mardiguian S, Austin Taylor M, von Wilamowitz-Moellendorff C

Is There a Lack of Dietary Data Collection in Real-World IBD Studies? Literature Review and Future Considerations

Neil R. Brett, Garthiga Manickam, Marielle Bassel, Daniela Castano, John S. Sampalis

Predictors of Post-Operative Complications Following Cytoreductive Surgery with HIPEC: A Real-World Analysis of 493 Patients in Québec

Vincent McCarty, Mikael Soucisse, Lucas Sideris, Neil R. Brett, Marielle Bassel, John Sampalis

Quantifying the Therapeutic Benefit of External Beam Radiotherapy in Uterine Serous Carcinoma: A Real-World Study

Elefterios P. Samartzis, Lucy Gilbert, Vincent McCarty, Neil R. Brett, Marielle Bassel, John Sampalis

Patient Perspectives on Mild-Moderate Infection Burden in Multiple Myeloma and Chronic Lymphocytic/Small Lymphocytic Leukemia

Matthew Quaife, Chiara Whichell, Gabriela Fernandez, Quazi Ataher, Bharat Ramakrishna, Julia Braverman

Patient and Caregiver Perspectives on Relapsed/Refractory Acute Myeloid Leukemia Treatments: A Qualitative Interview Study 

Sophie Van Tomme, Joshua Libbrecht, Rosanne Janssens, Harrison Clarke, Paul Cordero, Chantal el-Haddad, Matthew Quaife

Wednesday, 12 Nov

Session 5

Treatment Patterns and Healthcare Resource Utilisation in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in England: A Retrospective, Observational Cohort Study

Guillonneau S, Saeed O, Smolkina E, Petruski-Ivleva N, Seluzhytsky A, Nunez M, Pulfer A, Wolf A

Persistence to basal insulin and economic outcomes among patients with type 2 diabetes: A retrospective analysis using electronic health records in England

Bain SC, Bortolini M, Kiritharan S, Davidson JA, Wan Yau Ming S, Adebanjo YV

Uncovering Patient Narratives of Opioid Use and Recovery Using Large Language Models for Topic and Emotion Analysis of Social Media Discussions

Rai AK, Ikoro V, Berger A, Bhandary D, Ng A, Dabbous F

Understanding Trends and Opinions on More Environmentally Friendly Healthcare: A Clinician Survey

Marczell K, Chapman R, Cohen M, Benedict A

Using a Large Language Model (LLM) for Data Extraction of Studies: Learnings from a Targeted Literature Review (TLR) in Non-small Cell Lung Cancer (NSCLC)

Farraia M, Pandey A, Priedane E, Cichewicz A, von Wilamowitz-Moellendorff C

Therapeutic Benefit of Radiotherapy in Uterine Serous Carcinoma (USC): A Real-World Study

Elefterios (Pierre) Samartzis, Lucy Gilbert, Vincent McCarty, Neil R. Brett, Marielle Bassel, John Sampalis

Why Are Patient-Reported Outcome Measure (PROM) Results Missing From Labels of Obesity Management Medications?

Liberato A, Karn H, Anatchkova M, Skalicky A, Jionco A

You’ve Been Framed: The impact of risk and time framings on contraceptive preferences elicited through a discrete choice experiment

Matthew Quaife, Giulia Chandiet

Get in touch